The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
Official
·
business
·
Aug 20, 2026
From Covid to Cancer: How Moderna’s Stock Jumped 177% in a Day
B
By Rebecca Robbins
📖 1 min read
👁 1 view
💬 0 comments
📨 Enjoy this article?
Get stories like this in your inbox every week.
💬 Discussion (0)